| | | | Outcome of Operation Committee Meeting | 3/16/2012 4:09:38 PM | | | | Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company, at its Operation Committee Meeting held on March 16, 2012, allotted 20,450 shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003. | |
|